Maikelong Biotechnology

Maikelong Biotechnology was founded in 2022. The company is a high-tech enterprise based on microfluidic technology, applied in three niche sectors: medical aesthetics, drug delivery, and nuclear medicine. It integrates research and development, production, and sales. It is reported that Maikelong Biotechnology is a commercialization project of Sichuan University, with its technology originating from nearly 20 years of accumulation at the Membrane Science and Functional Materials Laboratory of Sichuan University. This team was the first internationally to develop microfluidic technology capable of controllably constructing high-performance multiple emulsions and also invented a novel method for preparing microscale functional materials using microfluidics.